Opinion

Video

Unmet Needs and Gaps in AD

Author(s):

Christopher G. Bunick, MD, PhD,Jonathan Silverberg, MD, PhD, MPH

Dermatologists outline unmet needs in the treatment landscape for atopic dermatitis and discuss how to potentially improve the standard of care for patients with atopic dermatitis.

Video content above is prompted by the following:

  • What continue to be the major areas of gaps in raising the standard of care in atopic dermatitis?
Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Related Content
Video Education Program Reduced Severity Score of Atopic Dermatitis in Pediatric Patients
November 15th 2024

Video Education Program Reduced Severity Score of Atopic Dermatitis in Pediatric Patients

Tim Smith
Advances in Pediatric Eczema Highlight 2022
December 21st 2022

Advances in Pediatric Eczema Highlight 2022

Kevin Kunzmann
Dr. Erica Spatz at Yale School of Medicine
November 12th 2024

New Study Compares Approaches to Control High Blood Pressure

Rachel Martin
How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care
July 12th 2022

How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care

Armand Butera
MJH Life Sciences logo over a white background. | Credit: MJH Life Sciences
November 11th 2024

MJH Life Sciences Celebrates Acquisition of Revolutionizing Atopic Dermatitis (RAD) Annual Meeting

Patrick Campbell
Dupilumab for Atopic Dermatitis Sustained Efficacy in Clinical Signs, PROs Over 3 Years
November 11th 2024

Dupilumab for Atopic Dermatitis Sustained Efficacy in Clinical Signs, PROs Over 3 Years

Tim Smith
© 2024 MJH Life Sciences

All rights reserved.